Drug Report History #106800
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated (Changed) | Updated to: 2021-01-18 | Was: 2020-02-20 |
| Drug Identification Number | 00745626 | 00745626 |
| Brand name | HUMATROPE | HUMATROPE |
| Common or Proper name | Somatropin for injection | Somatropin for injection |
| Company Name | ELI LILLY CANADA INC | ELI LILLY CANADA INC |
| Ingredients | SOMATROPIN | SOMATROPIN |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS | INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size (Changed) | Updated to: 5 mg vial | Was: 5 mg/vial |
| Additional packaging sizes | ||
| ATC code | H01AC | H01AC |
| ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date (Changed) | Updated to: 2021-01-15 | Was: 2020-11-01 |
| Actual discontinuation date (Changed) | Updated to: 2021-01-15 | Was: |
| Remaining supply date (Changed) | Updated to: 2021-01-15 | Was: 2020-11-01 |
| Discontinuation status (Changed) | Updated to: Discontinued | Was: To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions. | Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions. |
| Health Canada comments |